Sandimmune and disease progression Patient Reports February 12, 2012

Sandimmune Side Effects Report #4674605-7
Sandimmune side effect was reported by a Physician from on Dec 16, 2004. Male patient, 58 years of age, weighting 235.9 lb, was diagnosed with lung transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, obliterative bronchiolitis, pneumonia , respiratory failure. Sandimmune dosage: 250 MG / DAY. During the same period patient was treated with IMUREL, PREDNISOLONE. Patient was hospitalized. Patient died on 05/05/2005.

Sandimmune Side Effects Report #4700992-7
Sandimmune side effect was reported by a Physician from on Dec 16, 2004. Male patient, 58 years of age, weighting 235.9 lb, was diagnosed with lung transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, obliterative bronchiolitis, pneumonia , respiratory failure. Sandimmune dosage: 250 MG / DAY. During the same period patient was treated with IMUREL, PREDNISOLONE. Patient was hospitalized. Patient died on 05/05/2005.

Sandimmune Side Effects Report #4826463-5
Sandimmune side effect was reported by a Physician from DENMARK on Dec 16, 2004. Male patient, 58 years of age, weighting 235.9 lb, was diagnosed with lung transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: blood creatinine increased, disease progression, dyspnoea, hypoglycaemia, obliterative bronchiolitis, pneumonia , respiratory failure, transplant rejection. Sandimmune dosage: 250 MG / DAY. During the same period patient was treated with IMUREL, PREDNISOLONE. Patient was hospitalized. Patient died on 05/04/2005.

Sandimmune Side Effects Report #5228551-0
Sandimmune side effect was reported by a Physician from GERMANY on Jan 23, 2007. Male patient, 48 years of age, weighting 176.4 lb, was diagnosed with liver transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, cholangitis, cholestasis, disease progression, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased, hepatitis c virus. Sandimmune dosage: 500 MG, BID. Patient was hospitalized. Patient recovered.


Sandimmune Side Effects Report #5238298-2
Sandimmune side effect was reported by a Physician from GERMANY on Feb 06, 2007. Male patient, 48 years of age, weighting 176.4 lb, was diagnosed with liver transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, bile duct stent insertion, cholangitis, cholestasis, disease progression, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased. Sandimmune dosage: 500 MG, BID. During the same period patient was treated with CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #5245111-6
Sandimmune side effect was reported by a Physician from GERMANY on Feb 15, 2007. Male patient, 48 years of age, weighting 176.4 lb, was diagnosed with liver transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, bile duct stent insertion, cholangitis, cholestasis, disease progression, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased. Sandimmune dosage: 500 MG, BID. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #5307401-8
Sandimmune side effect was reported by a Physician from GERMANY on Apr 18, 2007. Male patient, 48 years of age, weighting 176.4 lb, was diagnosed with liver transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, bile duct stent insertion, cholangitis, cholestasis, disease progression, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased. Sandimmune dosage: 500 MG, BID. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #5307441-9
Sandimmune side effect was reported by a Physician from GERMANY on Apr 18, 2007. Male patient, 48 years of age, weighting 176.4 lb, was diagnosed with liver transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, bile duct stent insertion, cholangitis, cholestasis, disease progression, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased. Sandimmune dosage: 500 MG, BID. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #5385029-1
Sandimmune side effect was reported by a Physician from GERMANY on July 05, 2007. Male patient, 48 years of age, weighting 176.4 lb, was diagnosed with liver transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, bile duct stent insertion, cholangitis, cholestasis, disease progression, endoscopic retrograde cholangiopancreatography, hepatic cirrhosis. Sandimmune dosage: 500 MG, BID. Patient was hospitalized. Patient recovered.


Sandimmune Side Effects Report #5385123-5
Sandimmune side effect was reported by a Physician from GERMANY on July 05, 2007. Male patient, 48 years of age, weighting 176.4 lb, was diagnosed with liver transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, bile duct stent insertion, cholangitis, cholestasis, disease progression, endoscopic retrograde cholangiopancreatography, hepatic cirrhosis. Sandimmune dosage: 500 MG, BID. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #4764566-4
Sandimmune side effect was reported by a Physician from SWEDEN on Aug 29, 2005. Female patient, 56 years of age, weighting 90.39 lb, was diagnosed with heart transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: back pain , blood creatinine increased, disease progression, osteoporotic fracture, spinal compression fracture. Sandimmune dosage: unknown. During the same period patient was treated with DICLOFENAC. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #4785887-5
Sandimmune side effect was reported by a Physician from SWEDEN on Aug 29, 2005. Female patient, 56 years of age, weighting 90.39 lb, was diagnosed with heart transplant  and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: back pain , blood creatinine increased, disease progression, osteoporotic fracture, spinal compression fracture. Sandimmune dosage: unknown. During the same period patient was treated with DICLOFENAC. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #5419030-6
Sandimmune side effect was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Male patient, child 11 years of age, was diagnosed with focal glomerulosclerosis and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: blood creatinine increased, cytogenetic abnormality, disease progression, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, renal failure chronic, tubulointerstitial nephritis. Sandimmune dosage: 75 MG/DAY. During the same period patient was treated with NEORAL. Patient recovered.

Sandimmune Side Effects Report #5419031-8
Sandimmune side effect was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Male patient, child 11 years of age, was diagnosed with focal glomerulosclerosis and was treated with Sandimmune. After drug was administered, patient experienced the following side effects: blood creatinine increased, cytogenetic abnormality, disease progression, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, renal failure chronic, tubulointerstitial nephritis. Sandimmune dosage: 75 MG/DAY. During the same period patient was treated with NEORAL. Patient recovered.